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1. Introduction 
Terminal deoxynucleotidyl transferase (TdT) cat- 
alyzes the primer-dependent but template-independent 
DNA polymerization of deoxynucleoside 5’-triphos- 
phates; the enzyme was discovered and purified to 
homogeneity by Bollum [ 1,2]. The TdT is only present 
in thymus, in bone marrow [3] and in blood lympho- 
blasts of patients with acute lymphoblastic leukemia 
[4]. TdT has also been reported to be present in 
nonthymic cells [5], as well as in germinating wheat 
embryo [6]; for a critical reexamination of these 
observations an optimized TdT assay [2,7] and spe- 
cific inhibitors are necessary. To establish these pre- 
requisites proper experiments with purified TdT 
preparations must be performed. 
In the present study it is shown that the activity of 
a 700-fold enriched TdT preparation from thymus is 
competitively inhibited by ATP, 3’-deoxyadenosine 
triphosphate (3’-dATP; cordycepin triphosphate) and 
9.O-D-arabinofuranosyladenine 5’-triphosphate 
@araATP) with respect to both the natural substrate 
2’-dATP (dATP) and the initiator oligo [d(pA)a]. 
9-cwD-Arabinofuranosyladenine 5’-triphosphate 
(oaraATP) was found to exert no inhibitory effect 
toward TdT. 
2. Materials and methods 
2.1. Compounds 
The following materials were obtained d [r4C]ATP 
(spec. act. 52.8 mCi/mmol) from NEN, Boston, Mass.; 
poly(dA) from Miles, Elkhart, Ind.; BaraATP from 
Elsevier/North-Holland Biomedical IVess 
P-L Biochemicals, Milwaukee and ATP from Boehringer 
Mannheim, Tutzing. 
Poly (d [3H]A) (spec. act. 5000 cpm/nmol) was syn- 
thesized as in [8] and 3’-dATP as in [9]. aAraATP 
was a gift of Dr L. L. Bennett, jr (Kettering-Meyer 
Laboratory, Southern Research Institute, Birmingham, 
Al). 
2.2. TdTpun’fication 
TdT was prepared from calf thymus as in [2]; step 
VII with spec. act. 9400 units/mg protein (0.57 mg 
protein/ml) was used for the experiments. One unit 
of enzyme is equal to 1 mmol dATP incorporated 
into DNA per hour. 
2.3. TdT assay 
The enzyme was assayed in the following mixture 
(100 ti final vol.): 200 mM Kcacodylate (pH 7.2), 
1 mM 2.mercaptoethanol, 4 mM MgCla, 20 pg/ml 
bovine serum albumin, varying amounts of d [i4C]ATP 
(spec. act. 3qO cpm/nmol), 100 &l d(pA)3 as initiator 
and 1000 enzyme units/ml. In some experiments 
unlabelled dATP and 10 /&l d(p[3H]A)s (spec. act. 
5000 cpm/nmol) were used instead of d [r4C]ATP and 
d(pA)3. After incubation at 35°C for 1 h, the poly- 
nucleotides in 80 /..d ahquots were either collected on 
GF/C filters and processed as in [lo] or analyzed by 
paper chromatography. Under the conditions described, 
the reaction kinetics was linear with time. 
2.4. Inhibition analysis 
In the kinetic experiments to determine the Km 
for dATP, labeled dATP from l-10 PM was added to 
the assays; in the case of determining Km for the 
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initiator d(pA)a, unlabeled oligonucleotide assays 
from l-10 PM (and 200 MM labeled dATP) were used. 
The inhibitor constants (Ki> were calculated by the 
Lineweaver and Burk method [ 1 l] with the use of 
either a constant initiator concentration (100 r_1M 
d(pA)a), varying substrate concentrations (2.5 PM, 
5 /.IM or 10 PM dATP) and two different inhibitor 
concentrations (1.5 and 10 PM of the analogue) or a 
constant substrate concentration (200 PM labelled 
dATP), varying initiator concentrations (1 PM, 3 FM 
and 6 FM d(pA)a) and two different inhibitor concen- 
trations (1 E.IM and 5 PM of the triphosphate). Slopes 
and intercepts were calculated by linear regression 
analysis. 
The chain length of oligo(d [3H]A) was determined 
as in [9,12]; the strips were counted after treatment 
with 0.5 M NaCl [ 131. Protein was determined by 
Lowry’s method [ 141. Both unlabeled and radioactive 
d(pA), or d(pA)4 were prepared by limited degrada- 
tion of poly(dA) with DNase I [ 151. 
3. Results 
Under assay conditions, using 50 I.IM d[14C]ATP ar 
substrate and 100 PM d(pA), as initiator, the follow- 
ing dATP analogues inhibit the TdT-mediated DNA 
synthesis (table 1): 3’-dATP, ATP and @araATP. At 
100 I.IM analogue, 3’-dATP reduces the incorporation 
rate by 64%, ATP by 22% and ParaATP by 55%. The 
inhibition caused by craraATP is negligible. 
The type of inhibition of the different analogues 
in the TdT reaction was studied by the Lineweaver 
and Burk method [ 111. The inhibition kinetic con- 
stants were calculated either under constant substrate 
Table 1 
Inhibition of TdT by different dATP analogues 
Analogue 
01M) 
Incorporation rate 
(nmol/h) (%) 
_ 83.4 100 
3’-dATP, 100 30.0 36 
ATP, 100 65.1 78 
paraATP, 100 37.5 45 
oaraATP, 100 81.7 98 
The experiments were performed with 50 MM d[14C]ATP and 
100 rM d(pA), 
(dATP) concentrations and variation of the initiator 
d(pA)s concentration or in assays with d(pA)3 as 
variable component and dATP as constant component. 
The concentrations of the variable components were 
chosen in the range of their Km constant. The exper- 
iments revealed that the inhibition of 3’-dATP, ATP 
and /3araATP was of the competitive type, both with 
respect to the natural substrate dATP and to the 
initiator d(pA),. As a measure of the relative affinity 
of the enzyme for inhibitor and dATP or d(pA)3 in 
competitive inhibition, the ratio Ki:Km can be adopt- 
ed [ 161; the lower the value for KiXm, the stronger 
is the inhibitory potency of a substance. The highest 
affinity towards TdT activity was observed with 
3’-dATP as inhibitor in those assays containing sub- 
strate concentrations around the Km value and high 
initiator concentrations; ParaATP and ATP affect 
TdT reaction to a lower extent (table 2). In case 
d(pA), was the variable component (concentrations 
around K,,, value) and dATP (at the high concentra- 
tion of 200 PM) was constant component, the highest 
Table 2 
Inhibition analysis of TdT 
Analogue Km WI) Ki 
dATP OtM) 
Ki 
K, 
Km (rM) 
d(pA), 
Ki Ki 
(&I) 
- 
Km 
3’dATP 3.2 3.4 1.06 1.9 0.7 0.37 
ATP 3.2 21.7 6.78 1.9 4.2 2.21 
paraATP 3.2 4.9 1.53 1.9 16.1 8.47 
The inhibition &dies shown in the left section were peTformed with 100 PM d(pA), and d[“C]ATP as variable component; for 
those in the right section a constant substrate concentration (200 NM d[“C]ATP) and varying initiator concentrations were used. 
For further details, see section 2 
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affinity was observed with 3’dATP; the affinities of 
ATP and ParaATP to the enzyme (table 2) are lower. 
The finding indicating that 3’dATP and ATP 
inhibit TdT reaction sensitively in a competitive way 
with respect o the initiator led us to suggest that 
these analogues act as chain terminators. To prove 
this assumption, d(p[3H]A)s was incubated in the 
presence of the triphosphates dATP, 3’dATP, ATP 
or OaraATP; the respective product was subsequently 
chromatographed to determine the chain length of 
the oligonucleotide. In the case of incubation of 
d(p[3H]A), with dATP (fig.1 ; left) 34% total radio- 
activity is found at the origin (RF O-0.5); at this 
position only oligomers with a chain length of > 10 
dAMP moieties are found [ 12 3. Only 7% radioactivity 
is found at the RF value, characteristic for d@A)a. If 
the oligomer is incubated with 3’dATP (fig.1 ; left) 
virtually no radioactivity is detected at RF 0; 66% is 
recovered at the position ofd(pA)a and 28% at d(pA)+ 
In fig. 1 (right) the radioactivity pattern of the product 
after incubation of d(p [3H]A)s with ATP and ParaATP 
is shown. If incubated with ATP 32% radioactive 
product is identified as d(pA)4, 65% total oligonucle- 
otide did not serve as initiator and is found at d@A)a. 
In the case of incubation of d@A)a with ParaATP a 
radioactivity pattern is found which shows no pro- 
oligo dW3 
n 
olioo d 1 PA\ 
nounced peak; this observation i dicates that most of 
d(pA)a has undergone an enzymic reaction resulting 
in oligomer formation of not only high molecular 
weights but also of intermediate low molecular 
weights. 
4. Discussion 
The sensitivity of the purified TdT towards ATP 
(one substrate of the RNA polymerases), 3’-dATP (a 
selective inhibitor of RNA-synthesizing polymerases 
[9]), /?araATP (an inhibitor of DNA polymerase a! and 
0; [ 171 and craraATP (a selective inhibitor of DNA 
polymerase CY [181) in an assay with dATP and oligo- 
[d(pA)J was tested. Under the assay conditions used, 
aaraATP was without influence on TdT activity. The 
other 3 triphosphates were found to inhibit sensitively 
TdT-mediated DNA synthesis; the inhibition was of 
the competitive type both with respect o dATP and 
oligo [d(pA)sJ. While ParaATP does not function as 
chain terminator, 3’dATP and ATP obviously inhibit 
the TdT reaction by reducing the initiator capacity 
for this enzyme. The conclusion that 3’dATP and 
ATP act as chain terminator must be drawn from the 
experiments which revealed that after incubation of 
d ipAlL d (pAI3 
I I 
Rf value 
Fig.1. Chain Length of oligo [d(pa)] after incubation with TdT and different nucleoside triphosphates. 10 NM d(p[‘H]A)$ were 
added to the TdT reaction mixture and incubated in the presence of dATP, 3’dATP, ATP or ParaATP at 100 MM. After incuba- 
tion (1 h, 35°C) a 80 ~1 aliquot was analyzed by paper chromatography to determine the chain length of oligo [d@[3H]A)J. 
Radioactivity pattern of the product after incubation with dATP (- ) and 3’dATP (---) (left), or with ATP ( -) and 
paraATP (---) (right). The bars mark the positions of the authentic compounds. 
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oligo [d(pA)s] with 3’.dATP or ATP only tetranucle- 
otide products are formed. 
These data demonstrated that 3’dATP and ATP 
are 2 selective inhibitors for TdT; they are inactive in 
DNA-synthesizing systems both with DNA polymer- 
ase o or fl as enzyme [9,19]. 
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